Vitamin C

( DrugBank: - / KEGG DRUG: - )

---

6 diseases

10. シャルコー・マリー・トゥース病

---

臨床試験数 : 45 / 薬物数 : 34 - (DrugBank : 10) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 22 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

192. コケイン症候群

---

臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 49 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

206. 脆弱Ｘ症候群

---

臨床試験数 : 118 / 薬物数 : 75 - (DrugBank : 30) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 83 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

210. 単心室症

---

臨床試験数 : 56 / 薬物数 : 49 - (DrugBank : 25) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 77 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

211. 左心低形成症候群

---

臨床試験数 : 23 / 薬物数 : 29 - (DrugBank : 11) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 13 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

212. 三尖弁閉鎖症

---

臨床試験数 : 5 / 薬物数 : 5 - (DrugBank : 6) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 13 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries